These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2468849)

  • 41. Effects of Ca2+ entry blockers on CaCl2-, KCl- and noradrenaline-induced contractions of goat cerebral arteries.
    Salom JB; Torregrosa G; Miranda FJ; Alabadí JA; Alvarez C; Alborch E
    Eur J Pharmacol; 1990 Feb; 177(1-2):1-8. PubMed ID: 2111247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of extracellular calcium and of the calcium entry blockers flunarizine and nimodipine on contractile responses in human temporal arteries.
    Jansen I; Edvinsson L
    Cephalalgia; 1986 Dec; 6(4):235-40. PubMed ID: 3802190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Ca2+ channel antagonist subtypes on mitochondrial Ca2+ transport.
    Uceda G; García AG; Guantes JM; Michelena P; Montiel C
    Eur J Pharmacol; 1995 Mar; 289(1):73-80. PubMed ID: 7540145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.
    Novalbos J; Abad-Santos F; Zapater P; Cano-Abad MF; Moradiellos J; Sánchez-García P; García AG
    Eur J Pharmacol; 1999 Feb; 366(2-3):309-17. PubMed ID: 10082213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.
    Agrotis A; Little PJ; Saltis J; Bobik A
    Eur J Pharmacol; 1993 Feb; 244(3):269-75. PubMed ID: 8458401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of calcium antagonists on the dopamine system.
    Mena MA; Garcia de Yébenes MJ; Tabernero C; Casarejos MJ; Pardo B; Garcia de Yébenes J
    Clin Neuropharmacol; 1995 Oct; 18(5):410-26. PubMed ID: 8665555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative studies on the effects of the nootropic drug adafenoxate and of the cerebral vasodilator flunarizine on arterial smooth muscles.
    Todorov S; Petkov V
    Acta Physiol Pharmacol Bulg; 1988; 14(3):10-6. PubMed ID: 3146886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels.
    Chulia T; Gonzalez P; Del Rio M; Tejerina T
    Eur J Pharmacol; 1995 Oct; 285(2):115-22. PubMed ID: 8566128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. d-Tubocurarine as a dopaminergic antagonist in the rabbit ear artery.
    Nelson SH; Steinsland OS
    Anesthesiology; 1983 Aug; 59(2):98-101. PubMed ID: 6135375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of calcium channel blockers on behaviors induced by the N-methyl-D-aspartate receptor antagonist, dizocilpine, in rats.
    Sukhotina IA; Dravolina OA; Medvedev IO; Bespalov AY
    Pharmacol Biochem Behav; 1999 Aug; 63(4):569-80. PubMed ID: 10462185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues.
    Mecca TE; Love SD
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atherosclerosis, calcium, and calcium antagonists.
    Henry PD
    Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
    [No Abstract]   [Full Text] [Related]  

  • 54. Secretion of active and inactive renin by rabbit kidney cortex slices: effects of verapamil, flunarizine and A23187.
    Ginesi LM; Noble AR
    Clin Exp Hypertens A; 1984; 6(7):1331-43. PubMed ID: 6088131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A nimodipine-resistant Ca2+ pathway is involved in myogenic tone in a resistance artery.
    Hwa JJ; Bevan JA
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H182-9. PubMed ID: 2942041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmentation by calcium channel antagonists of general anaesthetic potency in mice.
    Dolin SJ; Little HJ
    Br J Pharmacol; 1986 Aug; 88(4):909-14. PubMed ID: 2943355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of flunarizine-induced vasodilation in the rabbit mesenteric artery.
    Itoh T; Satoh S; Ishimatsu T; Fujiwara T; Kanmura Y
    Circ Res; 1987 Sep; 61(3):446-54. PubMed ID: 3040296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation by endothelium of contractile responses in rat aorta in absence and presence of flunarizine.
    Miller RC; Stoclet JC
    Br J Pharmacol; 1985 Nov; 86(3):655-61. PubMed ID: 3864514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.
    Villarroya M; Gandía L; Lara B; Albillos A; López MG; García AG
    Br J Pharmacol; 1995 Jan; 114(2):369-76. PubMed ID: 7881736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens.
    Hay DW; Wadsworth RM
    Br J Pharmacol; 1982 May; 76(1):103-13. PubMed ID: 7082900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.